FDA inspection
Aino Co., Ltd. of North China Pharma. Group: FDA inspection ending Jun 6, 2014
FDA inspection 888168 · Voluntary Action Indicated (VAI) · Shijiazhuang, Hebei
Key facts
| Inspection ID | 888168 |
|---|---|
| Firm | Aino Co., Ltd. of North China Pharma. Group |
| FEI number | 3004090057 |
| Address | 31 Xingye Street, Economic And Technical Development Zone |
| City | Shijiazhuang, Hebei |
| Country | China |
| Fiscal year | 2014 |
| Inspection end date | Jun 6, 2014 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data